Technology Innovation Institute’s Cryptography Research Centre in Abu Dhabi Collaborates with Yale University
6.1.2021 13:15:00 EET | Business Wire | Press release
Abu Dhabi and the UAE are working to pioneer breakthroughs in post-quantum cryptography and neuromorphic computing through an international partnership between Technology Innovation Institute’s (TII) Cryptography Research Centre (CRC) and Yale University, an Ivy League research university in Connecticut, United States.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210106005376/en/
Dr. Najwa Aaraj, Chief Researcher at Cryptography Research Centre (Photo: AETOSWire)
The two institutions will first join forces on ‘Post-Quantum Lightweight Crypto Hardware Accelerators and Trusted Execution Environment Designs’, a project at the intersection of emerging technologies that focuses on developing quantum-resistant crypto schemes within the context of emerging quantum algorithms that can be run on a sufficiently large quantum computer. By leveraging post-quantum cryptographic (PQC) algorithms, the project aims to guarantee the necessary measures of security even as today’s public cryptographic standards, such as RSA and Elliptic Curve Cryptography (ECC), become ineffective when a powerful quantum computer is built and can run Shor’s quantum algorithm. The project is also exploring post-quantum lightweight cryptography with a focus on highly constrained devices.
The neuromorphic computing project, ‘Energy-based Probing for Robust and Explainable Spiking Neural Networks’, takes inspiration from the brain to create energy-efficient hardware for information processing and is capable of highly sophisticated tasks. The project examines Spiking Neural Networks (SNNs), which have become popular as an energy-efficient alternative for implementing standard artificial intelligence tasks. Spikes or binary events drive communication and computation in SNNs that are close to biological neuronal processing and offer the benefit of event-driven hardware operations.
The central focus of the collaboration is to explore the design space of the energy-accuracy-robustness-explainability trade-off and to design the hardware/software necessary to create truly functional intelligent systems. To ensure there is no overlap, both entities have been tasked with managing specific areas of the research in both projects.
Speaking on the partnership, Dr Najwa Aaraj, Chief Researcher at Cryptography Research Centre, said: “We are excited to work with peers from Yale University in carrying out groundbreaking research in these two vital fields. At the Cryptography Research Centre, we are creating a knowledge-driven ecosystem powered by like-minded scientists and researchers – all focused on designing breakthrough solutions in different areas of cryptography.”
Jakub Szefer, Associate Professor of Electrical Engineering and Computer Science, and Priya Panda, Assistant Professor of Electrical Engineering, from Yale University, said: “By working collaboratively with Cryptography Research Centre, we have an opportunity to apply shared expertise across post-quantum cryptography and neuromorphic computing research. We are optimistic that this partnership will yield effective research outcomes for greater impact.”
Technology Innovation Institute, the ‘applied research’ pillar of Advanced Technology Research Council (ATRC), is a pioneering global research and development centre that focuses on applied research and new-age technology capabilities. The institute has seven initial dedicated research centres in quantum, autonomous robotics, cryptography, advanced materials, digital security, directed energy and secure systems. By working with exceptional talent, universities, research institutions and industry partners from all over the world, the Institute connects an intellectual community and contributes to building an R&D ecosystem in Abu Dhabi and the UAE. The Institute reinforces Abu Dhabi and the UAE’s status as a global hub for innovation and contributes to the broader development of the knowledge- based economy.
For more information about Cryptography Research Centre (CRC) please visit
tii.ae/cryptographytii.ae/cryptography
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005376/en/
Contact information
Technology Innovation Institute
Aisha Shaikh, +971555423718
aisha.shaikh@tii.ae
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 11:01:00 EEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
